ATE315042T1 - 9a-azalide mit antibakterieller wirkung - Google Patents

9a-azalide mit antibakterieller wirkung

Info

Publication number
ATE315042T1
ATE315042T1 AT00955256T AT00955256T ATE315042T1 AT E315042 T1 ATE315042 T1 AT E315042T1 AT 00955256 T AT00955256 T AT 00955256T AT 00955256 T AT00955256 T AT 00955256T AT E315042 T1 ATE315042 T1 AT E315042T1
Authority
AT
Austria
Prior art keywords
azalide
antibacterial effect
antibacterial
effect
Prior art date
Application number
AT00955256T
Other languages
English (en)
Inventor
Yat Sun Or
Robert F Keyes
Zhenkun Ma
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE315042T1 publication Critical patent/ATE315042T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
AT00955256T 1999-08-24 2000-07-26 9a-azalide mit antibakterieller wirkung ATE315042T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38216699A 1999-08-24 1999-08-24

Publications (1)

Publication Number Publication Date
ATE315042T1 true ATE315042T1 (de) 2006-02-15

Family

ID=23507795

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00955256T ATE315042T1 (de) 1999-08-24 2000-07-26 9a-azalide mit antibakterieller wirkung

Country Status (15)

Country Link
EP (1) EP1206476B1 (de)
JP (1) JP2003507487A (de)
AR (1) AR025379A1 (de)
AT (1) ATE315042T1 (de)
AU (1) AU6748500A (de)
BR (1) BR0009101A (de)
CA (1) CA2380455C (de)
CY (1) CY1104996T1 (de)
DE (1) DE60025370T2 (de)
DK (1) DK1206476T3 (de)
ES (1) ES2256030T3 (de)
HK (1) HK1047940B (de)
MX (1) MXPA02001897A (de)
PT (1) PT1206476E (de)
WO (1) WO2001014397A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
WO2005070918A1 (en) 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
CA3130061A1 (en) 2013-04-04 2014-10-09 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ １４員ケトライドならびにそれらの調製および使用の方法
CA2980315A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
SI8611592A8 (en) * 1986-09-12 1995-04-30 Pliva Pharm & Chem Works Process for preparing complexes of N-methyl-11-aza-10-deoxo-10-dihydroeritromicine A and 11-aza-10-deoxo-10-dihydroeritromicine A with metals
EP0699207B1 (de) * 1993-05-19 1997-06-25 Pfizer Inc. Zwischenprodukt für azithromycin
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
AU7961498A (en) * 1997-06-26 1999-01-19 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment
WO1999000125A1 (en) * 1997-06-27 1999-01-07 Merck & Co., Inc. 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
EP1101769A3 (de) * 1999-11-18 2001-10-24 Pfizer Products Inc. Stickstoff-enthaltend Erythromycin-Derivate

Also Published As

Publication number Publication date
JP2003507487A (ja) 2003-02-25
AU6748500A (en) 2001-03-19
MXPA02001897A (es) 2002-10-31
DE60025370T2 (de) 2006-09-21
CY1104996T1 (el) 2010-03-03
CA2380455A1 (en) 2001-03-01
EP1206476B1 (de) 2006-01-04
HK1047940A1 (en) 2003-03-14
WO2001014397A1 (en) 2001-03-01
EP1206476A1 (de) 2002-05-22
PT1206476E (pt) 2006-05-31
CA2380455C (en) 2009-06-02
AR025379A1 (es) 2002-11-20
BR0009101A (pt) 2002-02-05
DE60025370D1 (de) 2006-03-30
ES2256030T3 (es) 2006-07-16
HK1047940B (zh) 2006-11-03
DK1206476T3 (da) 2006-05-15

Similar Documents

Publication Publication Date Title
DE60014893D1 (de) Pyrazolobenzodiazepine mit cdk2 hemmender wirkung
DE60006227D1 (de) Antimikrobielle gegenstände
ATE329566T1 (de) Pflaster mit magnetischer wirkung
PT1206469E (pt) Fenil-oxazolidinonas substituidas heterociclicas antibacterianas
DE69934805D1 (de) Substituierte imidazole mit cytokin-inhibierender wirkung
DE60036160D1 (de) Elektroentionisierungsvorrichtung
DE60113450D1 (de) Antimikrobielle chinolone
NO20021183D0 (no) Antimikrobielle tilsetningsstoffer
NO20010916L (no) Nye antibakterielle isoksazolinoner
NO20015722D0 (no) Antibakterielle forbindelser
DE69908338D1 (de) 15-gliedrige ketolid-lactame mit antibakterieller wirkung
NO20015744D0 (no) Bredspektrede antimikrobielle blandinger
DE60125678D1 (de) Vermittlungstelle mit Flusssteurungverwaltung
ATE473985T1 (de) Tricyclische tetrahydrochinoline mit antibakterieller wirkung
ATE258754T1 (de) Antimikrobieller polymer
DE69927008D1 (de) Verbindungen mit kalzilytischer wirkung
ATE408596T1 (de) Pleuromutilinderivate mit antibakterieller wirkung
NO20020621D0 (no) Antibakterielle midler
ATE264843T1 (de) Antibakterielle mutiline
DK1185237T3 (da) Synergistisk antibakteriel kombination
DE60025370D1 (de) 9a-azalide mit antibakterieller wirkung
IS6223A (is) Fjölbrigða salt
ATE235491T1 (de) Phenylpyrazole mit herbizider wirkung
ID25567A (id) Ulir-jepit dengan bahu-puntir
DE60004623D1 (de) Biozidmaterial mit verbesserter Wirkung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1206476

Country of ref document: EP

REN Ceased due to non-payment of the annual fee